What is the dosage range for Zoloft (sertraline) in treating Post-Traumatic Stress Disorder (PTSD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline Dosing for PTSD

For Post-Traumatic Stress Disorder, start sertraline at 25 mg once daily for one week, then increase to 50 mg once daily, with a therapeutic range of 50-200 mg/day. 1

Initial Dosing Protocol

  • Begin with 25 mg once daily for the first week to minimize initial side effects, particularly in PTSD patients who may be sensitive to activation 1
  • After one week, increase to 50 mg once daily, which serves as the initial therapeutic dose 1
  • Administer once daily, either morning or evening based on patient tolerance 1

Dose Titration Strategy

  • Patients not responding to 50 mg may benefit from dose increases up to a maximum of 200 mg/day 1
  • Do not change doses at intervals less than 1 week due to sertraline's 24-hour elimination half-life 1
  • The clinical trials demonstrating efficacy used a dose range of 50-200 mg/day, with a mean effective dose around 70 mg/day 1, 2
  • In the pivotal multicenter trial, flexible dosing between 50-200 mg/day resulted in a 60% responder rate versus 38% for placebo 2

Maintenance Treatment

  • PTSD requires several months or longer of sustained pharmacological therapy beyond initial response 1
  • Sertraline efficacy is maintained for periods up to 28 weeks following 24 weeks of initial treatment at doses of 50-200 mg/day 1
  • Periodically reassess patients to determine ongoing need for maintenance treatment 1
  • The dose needed for maintenance may be the same as that required for initial response, though this has not been definitively established 1

Common Pitfalls and Monitoring

  • Insomnia is the most common adverse effect (35% vs 22% placebo), followed by diarrhea (28% vs 11%), nausea (23% vs 11%), fatigue (13% vs 5%), and decreased appetite (12% vs 1%) 2
  • The discontinuation rate due to adverse events is low (9% for sertraline vs 5% for placebo) 2
  • Significant improvement typically begins at week 2 and continues through week 12 3
  • Sertraline demonstrates efficacy across all three PTSD symptom clusters: avoidance/numbing, hyperarousal, and reexperiencing 3

MAOI Interactions

  • Allow at least 14 days between discontinuing an MAOI and starting sertraline 1
  • Allow at least 14 days after stopping sertraline before starting an MAOI 1
  • Do not start sertraline in patients receiving linezolid or intravenous methylene blue due to serotonin syndrome risk 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.